5590504311 · Stockholm
Källa: Bolagsverket och SCB, egen bearbetning
Developeration AB has registration number 559050-4311. Net revenue was 0.00 MSEK for the period ending 31 Dec 2022. Operating result was -2.83 MSEK for the period ending 31 Dec 2024. Reported average number of employees: 1 (31 Dec 2024).
Latest value for each metric. Each value shows its own period.
31 Dec 2021 → 31 Dec 2024 · The comparison contains 19 material changes.
| −184 % | Result after financial items | -1.29 MSEK → -3.65 MSEK | |
| −184 % | Result before tax | -1.29 MSEK → -3.65 MSEK | |
| −184 % | Net result | -1.29 MSEK → -3.65 MSEK |
Net revenue · MSEK
| Period | Net revenue |
|---|---|
| 2018-12 | 0.0 |
| 2019-12 | 0.2 |
| 2021-12 | 0.0 |
| 2022-12 | 0.0 |
Net revenue covers sales. Operating turnover is net revenue plus other operating income. Operating revenue, inventory changes and other items is a separate reported line.
| Financials | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|---|---|---|
| Net revenue MSEK | — | — | — | ||||
| Operating revenue, inventory changes and other items MSEK | — | — | — | ||||
| Operating result MSEK | |||||||
| Result after financial items MSEK | |||||||
| Result before tax MSEK | — | — | — | ||||
| Net result MSEK | — | — | — | ||||
| Personnel costs MSEK | — | — | — | ||||
| Employees people | |||||||
| Total assets MSEK | — | — | |||||
| Equity MSEK | — | — | — | ||||
| Unrestricted equity MSEK | — | — | — | ||||
| Share capital MSEK | — | — | — | ||||
| Cash & bank MSEK | — | — | — | ||||
| Short-term debt MSEK | — | — | — | ||||
| Long-term debt MSEK | — | — | — | — | — | ||
| Equity ratio % | |||||||
| Proposed dividend MSEK | — | — | — | — | — | — |
Some values are missing. They show a dash, never zero. Cost lines retain their source sign. A positive cost amount is subtracted in the income statement; missing lines are not treated as zero.
From the end of the fiscal year to filing with Bolagsverket. A long wait is a signal in itself.
| Period | Fiscal year end | Filed |
|---|---|---|
| 31 Dec 2024 | 31 Dec 2024 | 21 Jul 2025 · 202 days · Audited |
| 31 Dec 2021 | 31 Dec 2021 | 3 Jul 2022 · 184 days · Audited |
| Period | Filed | View evidence |
|---|---|---|
| 1 Jan 2024 → 31 Dec 2024 K3 | 21 Jul 2025 | |
| 1 Jan 2021 → 31 Dec 2021 K3 | 3 Jul 2022 |
Only digital annual reports are included. A missing year does not mean the authority has no filing.
For filings before 2025, the filing date represents the bulk-file week and may be approximate.
Bolaget skall bedriva konsult- och utbildningsverksamhet inom medicin, utveckla medicinskt tekniska produkter, vara verksam som holdingbolag samt bedriva aktiehandel.
The SCB employee class is a range. The reported average employee count is shown separately with its fiscal period.
Register facts: SCB/Bolagsverket, updated 30 Oct 2026.
Källa: Bolagsverket och SCB, egen bearbetning
2 digital filings are available in Bolagsdelta. The latest period ends 31 Dec 2024.
Källa: Bolagsverket och SCB, egen bearbetning
With Bolagsdelta Pro, keep the companies you follow together, compare full filings and review changes in your workspace.
Explore Pro5 signatories in the latest filing
Personal names are shown to signed-in users with the appropriate plan.
Verkställande direktör
Styrelseordförande
Styrelseledamot
Styrelseledamot
Styrelseledamot
Beräknade värden från rapporterade poster i årsredovisningarna, inte rapporterade nyckeltal. Varje punkt anger vilka poster och dokument som använts.
Colour compares each row with itself: darker is higher for that ratio. Click a cell for the calculation.
| Financials | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|---|---|---|
| EBIT margin | — | — | — | — | — | ||
| Margin after financial items | — | — | — | — | — | ||
| EBITDA | — | — | — | ||||
| Revenue per employee | — | — | — | — | — | ||
| Personnel costs per employee | — | — | — | ||||
| Quick ratio | — | — | — | — | — | ||
| Debt to equity | — | — | — | — | — | ||
| Revenue growth | — | — | — | — | — | — |
Källa: Bolagsverket och SCB, egen bearbetning
31 Dec 2024
7757 companies · 1-4 employees · nationwide
8942 companies · 1-4 employees · nationwide
9484 companies · 1-4 employees · nationwide
8193 companies · 1-4 employees · nationwide
Peers are companies with a digital annual report in the same industry (SNI, two digits), county and employee size class where at least 15 exist, otherwise a broader group.
Källa: Bolagsverket och SCB, egen bearbetning
SNI code 32.501 · Stockholm · TAB5693
The company's reporting period ends 31 Dec 2024. SCB's statistical year is shown above; the periods may differ.
A comparable company value is unavailable in this data.
A comparable company value is unavailable in this data.
58 companies in the SCB group.
Källa: SCB, egen bearbetning
HEJDEGATAN 55, 58243 LINKÖPING
Linköping · Östergötlands län
1-4 anställda
32501 · Tillverkning av medicinska och dentala instrument och tillbehör · 86102 · Specialiserad sluten somatisk hälso- och sjukvård på sjukhus
1 of 1 workplaces have a map position.
Each metric shows its statistical group and period. Company counts, leader ages and wages are national; regional series identify their county and industry group.
Stockholms län · industry group 05-39
Stockholms län · industry group 05-39
Sweden · industry section C · SCB · 2025
Monthly salary is an industry average. Personnel cost is the company's total reported cost, not an average salary.
Share of workplaces in Stockholms län, all industries.
Källa: SCB, egen bearbetning. Källa: Tillväxtanalys.
Net revenue was 0.00 MSEK for the period ending 31 Dec 2022.
Information is based on Bolagsverket and SCB, with our own processing. Each financial value links to its filing reference.
Bolagsdelta covers digital annual reports and available register information. A dash means the information is missing from our coverage, never that its value is zero.
Public company pages show roles and counts. Names and original documents require sign-in and the appropriate access.